[
  {
    "ts": null,
    "headline": "Palantir upgraded, Workday downgraded: Wall Street's top analyst calls",
    "summary": "Palantir upgraded, Workday downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=f350de4fccf6d4b163359d2635c64b32c5af3d372e017c22ec649a436f9620ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771426219,
      "headline": "Palantir upgraded, Workday downgraded: Wall Street's top analyst calls",
      "id": 139136638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Palantir upgraded, Workday downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=f350de4fccf6d4b163359d2635c64b32c5af3d372e017c22ec649a436f9620ad"
    }
  },
  {
    "ts": null,
    "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and More",
    "summary": "Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned positive by late morning, and all the indices ended the day modestly higher. With a trove of economic data on the way, and fourth-quarter ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and Mo",
    "url": "https://finnhub.io/api/news?id=b5e0c21a1be9e51549f167fa436b30d095085d6e3477e849fcf92aef1bbc7ab8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771420702,
      "headline": "Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and More",
      "id": 139136597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned positive by late morning, and all the indices ended the day modestly higher. With a trove of economic data on the way, and fourth-quarter ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Cadence Design, Crox, Genuine Parts, Kratos Defense, Medtronic, Palantir, StubHub, Transocean, and Mo",
      "url": "https://finnhub.io/api/news?id=b5e0c21a1be9e51549f167fa436b30d095085d6e3477e849fcf92aef1bbc7ab8"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic’s Q3 2026 revenues reach $9bn on strong PFA demand",
    "summary": "The cardiac ablation segment within Medtronic's cardiovascular portfolio grew 80% YoY, with PFA accounting for 80% of this revenue.",
    "url": "https://finnhub.io/api/news?id=c30e3961f7af8b0a6f586e6e844dbc010e6f02942a4f3bf4dec83ac1e12f2c2b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771419078,
      "headline": "Medtronic’s Q3 2026 revenues reach $9bn on strong PFA demand",
      "id": 139134144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The cardiac ablation segment within Medtronic's cardiovascular portfolio grew 80% YoY, with PFA accounting for 80% of this revenue.",
      "url": "https://finnhub.io/api/news?id=c30e3961f7af8b0a6f586e6e844dbc010e6f02942a4f3bf4dec83ac1e12f2c2b"
    }
  },
  {
    "ts": null,
    "headline": "Is Mixed Q3 Results, Robotics Win and Legal Hit Altering The Investment Case For Medtronic (MDT)?",
    "summary": "Medtronic plc has reported past third-quarter fiscal 2026 results showing revenue rising to US$9.02 billion from US$8.29 billion a year earlier, while net income eased to US$1.14 billion and diluted earnings per share from continuing operations slipped to US$0.89 from US$1.01. Alongside this mix of higher sales and softer profit, Medtronic secured U.S. FDA clearance for its Stealth AXiS spine robotics platform and faced a US$381 million antitrust jury award against it, highlighting both the...",
    "url": "https://finnhub.io/api/news?id=ac802d12bae4f7d43ea23bb0af570a96e7d382103d181bef8e818e9f8b32deb5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771413140,
      "headline": "Is Mixed Q3 Results, Robotics Win and Legal Hit Altering The Investment Case For Medtronic (MDT)?",
      "id": 139132692,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc has reported past third-quarter fiscal 2026 results showing revenue rising to US$9.02 billion from US$8.29 billion a year earlier, while net income eased to US$1.14 billion and diluted earnings per share from continuing operations slipped to US$0.89 from US$1.01. Alongside this mix of higher sales and softer profit, Medtronic secured U.S. FDA clearance for its Stealth AXiS spine robotics platform and faced a US$381 million antitrust jury award against it, highlighting both the...",
      "url": "https://finnhub.io/api/news?id=ac802d12bae4f7d43ea23bb0af570a96e7d382103d181bef8e818e9f8b32deb5"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic nets FDA clearance for robotic spine system",
    "summary": "Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.",
    "url": "https://finnhub.io/api/news?id=abebd0b096c704fd249db75a24ee926d3e82a3c07eab63e25b6b71dbc1ac409c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771412232,
      "headline": "Medtronic nets FDA clearance for robotic spine system",
      "id": 139137941,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes market share in the $15 billion cranial and spinal technologies sector.",
      "url": "https://finnhub.io/api/news?id=abebd0b096c704fd249db75a24ee926d3e82a3c07eab63e25b6b71dbc1ac409c"
    }
  },
  {
    "ts": null,
    "headline": "Baird Maintains Neutral on Medtronic, Lowers Price Target to $100",
    "summary": "Baird  analyst David Rescott   maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $103 to $100.",
    "url": "https://finnhub.io/api/news?id=3334f076ae02b02beb10200825b65c486367ab0baeea1236165f15d046f4b367",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771405628,
      "headline": "Baird Maintains Neutral on Medtronic, Lowers Price Target to $100",
      "id": 139134897,
      "image": "",
      "related": "MDT",
      "source": "Benzinga",
      "summary": "Baird  analyst David Rescott   maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $103 to $100.",
      "url": "https://finnhub.io/api/news?id=3334f076ae02b02beb10200825b65c486367ab0baeea1236165f15d046f4b367"
    }
  },
  {
    "ts": null,
    "headline": "Needham Maintains Buy on Medtronic, Lowers Price Target to $120",
    "summary": "Needham  analyst Mike Matson   maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $121 to $120.",
    "url": "https://finnhub.io/api/news?id=e078cd1fb09ba22e40fdae2a27e4d9bc345ff487c07c4399db421358af61705b",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771396400,
      "headline": "Needham Maintains Buy on Medtronic, Lowers Price Target to $120",
      "id": 139134898,
      "image": "",
      "related": "MDT",
      "source": "Benzinga",
      "summary": "Needham  analyst Mike Matson   maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $121 to $120.",
      "url": "https://finnhub.io/api/news?id=e078cd1fb09ba22e40fdae2a27e4d9bc345ff487c07c4399db421358af61705b"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Edges Higher: Investor Fear Eases Slightly, Greed Index Remains In 'Fear' Zone",
    "summary": "Medtronic and Orion post earnings, while investors await results from Analog Devices, Global Payments, and DoorDash.",
    "url": "https://finnhub.io/api/news?id=d38d5db5995ac8a633691ff61b6bd500cc339adcdb4b25eec5c0c10dd543e15e",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771383053,
      "headline": "S&P 500 Edges Higher: Investor Fear Eases Slightly, Greed Index Remains In 'Fear' Zone",
      "id": 139134217,
      "image": "https://cdn.benzinga.com/files/images/story/2026/02/18/Fear-and-Greed.jpeg?width=2048&height=1536",
      "related": "MDT",
      "source": "Benzinga",
      "summary": "Medtronic and Orion post earnings, while investors await results from Analog Devices, Global Payments, and DoorDash.",
      "url": "https://finnhub.io/api/news?id=d38d5db5995ac8a633691ff61b6bd500cc339adcdb4b25eec5c0c10dd543e15e"
    }
  }
]